Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The 'Therapeutic BCG Vaccine Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F' report has been added to ResearchAndMarkets.com's offering. The global landscape of the Therapeutic BCG Vaccine Market is undergoing a paradigm shift with the market size reaching a valuation of USD 128.54 million in 2022.

都柏林，2024年1月26日（环球通讯社）——ResearchAndMarkets.com的产品中增加了“治疗性卡介苗市场-2028F全球行业规模、份额、趋势、机遇和预测”报告。治疗性卡介苗市场的全球格局正在发生范式转变，2022年市场规模达到12854万美元。

Forecasted to expand at a CAGR of 6.37% until 2028, this surge signals a wave of progress over the next few years. Advances in biotechnology, heightened TB control efforts, and burgeoning research into new indications are earmarked as the key drivers propelling the market forward.Biotechnology Advancements Spearheading Market GrowthThe crux of the market growth can be attributed to remarkable biotechnological progress.

预计到2028年，复合年增长率将达到6.37%，这意味着未来几年将取得一波进展。生物技术的进步，结核病控制工作的加强以及对新适应症的新兴研究被指定为推动市场向前发展的关键驱动因素。生物技术进步引领市场增长市场增长的关键可归因于显着的生物技术进步。

Innovations such as CRISPR-Cas9 gene editing and advancements in genetic engineering are at the forefront, enhancing vaccine development and manufacturing, thereby cementing the BCG vaccine's role in contemporary medicine. These technological leaps are expected to play a pivotal role in expanding the therapeutic application and reliability of BCG vaccines.Rising Tuberculosis Control Efforts Boost BCG Vaccine DemandAs efforts to eradicate tuberculosis pick up pace globally, BCG vaccines, integral to TB prevention strategies, witness increasing demand.

CRISPR-Cas9基因编辑和基因工程进展等创新处于前沿，增强了疫苗的开发和制造，从而巩固了卡介苗在当代医学中的作用。预计这些技术飞跃将在扩大卡介苗的治疗应用和可靠性方面发挥关键作用。结核病控制工作的不断加强促进了卡介苗的需求随着全球根除结核病的步伐加快，卡介苗作为结核病预防战略的组成部分，需求不断增加。

TB control initiatives fueled by organizations like the WHO, alongside the vaccine's immunomodulatory actions, continue to invigorate the market. Moreover, with the pressing concern of drug-resistant TB strains, BCG vaccines emerge as a potentially effective adjunct therapy, adding to the overall demand.Expanding Research into New Indications Stimulates Market DynamicsExploratory research into novel therapeutic indications beyond bladder ca.

由世卫组织等组织推动的结核病控制举措，以及疫苗的免疫调节行动，继续活跃市场。此外，随着对耐药结核病菌株的迫切关注，卡介苗疫苗成为一种潜在有效的辅助疗法，增加了总体需求。扩大对新适应症的研究刺激了市场活力对膀胱ca以外的新型治疗适应症的探索性研究。